Understand the source comparison
FOXO4-DRI Not Working: FOXO4-DRI Peptide Preparation Comparison
The following table compares standard preparation approaches against optimized protocols that consistently deliver senolytic activity. Storage Temperature Room temp during shipping, fridge after arrival −20°C during shipping and storage, never above 8°C Standa
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The following table compares standard preparation approaches against optimized protocols that consistently deliver senolytic activity.
- Storage Temperature
- Room temp during shipping, fridge after arrival
- −20°C during shipping and storage, never above 8°C
- Standard: 15–30% activity loss before use. Optimized: full potency retained
- Temperature control is non-negotiable. Peptides aren't 'a little less effective' after heat exposure, they're structurally compromised
- Reconstitution Technique
- Inject water directly onto lyophilised cake, shake to dissolve
- Inject down vial wall at 45° angle, swirl gently, never shake
- Standard: visible aggregation in 20–40% of vials. Optimized: clear solution, no precipitate
- Aggregated peptide cannot cross cell membranes. Aggregation = protocol failure
- Dosing Calculation Basis
- Assume stated vial weight (e.g., 5mg)
- Use actual fill weight from COA or calculate by volume ratio
- Standard: ±10–20% dose variance. Optimized: <5% variance
- Systematic underdosing is the most common reason researchers report 'FOXO4-DRI doesn't work'
- Purity Verification
- Assume manufacturer's stated purity
- Verify purity via HPLC or request recent COA before reconstitution
- Standard: potential 5–10% underdosing from impurities. Optimized: accurate active peptide mass
- A 5mg vial at 90% purity contains 4.5mg active peptide. That's a dosing error large enough to move you out of the therapeutic window
- Aliquoting Strategy
- Reconstitute full vial, withdraw as needed over days/weeks
- Reconstitute, aliquot immediately into single-use volumes, freeze unused aliquots
- Standard: peptide degradation in solution over 7–14 days. Optimized: potency maintained across freeze-thaw cycles
- Repeated vial access introduces humidity, temperature fluctuations, and contamination. All of which degrade FOXO4-DRI
- Water Quality
- Sterile water or saline
- Bacteriostatic water for injection (0.9% benzyl alcohol)
- Standard: contamination risk on multi-draw vials. Optimized: sterility maintained
- BWFI allows safe multi-draw access without bacterial growth. Critical for protocols spanning multiple administrations